Skip to main content
. Author manuscript; available in PMC: 2024 Oct 2.
Published in final edited form as: Metabolomics. 2021 Jun 27;17(7):64. doi: 10.1007/s11306-021-01814-2

Table 1.

Baseline patient characteristics

Characteristics
Sex (F/M), N 24/26
Age (years), median (IQR) 6.5 (8.0)
BMI (kg/m2), median (IQR) 17.1 (4.0)
Initial Risk Factor*, N(%) Standard (29 [58%])
High (21 [42%])
Final Risk Factor**, N(%) Standard (25 [50%])
High (18 [36%])
Very High (7 [14%])

Age rage: 2.4–18.8 years. All the patients received the same induction chemotherapeutic agents

IQR interquartile range

*

Assigned based on age, presenting leukocyte count, immunopheno-type, central nervous system status

**

Assigned based on initial risk group, cytogenetics, and end-induction minimal residual disease levels